3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Laryngeal Neoplasms
3
Head and Neck Neoplasms
3
Uterine Cervical Neoplasms
2
Stomatitis
2
Squamous Cell Carcinoma of Head and Neck
2
Skin Neoplasms
2
Hematologic Neoplasms
2
Dyspareunia
2
Carcinoma, Hepatocellular
2
Carcinoma, Basal Cell
2
Breast Neoplasms
2
Vulvar Neoplasms
1
Vomiting
1
Vaginal Neoplasms
1
Urinary Bladder Neoplasms
1
Squamous Intraepithelial Lesions
1
Soft Tissue Neoplasms
1
Radiodermatitis
1
Prostatic Neoplasms
1
Papillomavirus Infections
1
Pain
1
Ovarian Neoplasms
1
Neoplasms
1
Mucositis
1
HIV Infections
1
Endometrial Neoplasms
1
Eczema
1
Dermatitis
1
Cicatrix
1
Cancer Pain
1
Interventions
Doxorubicin
18
Vincristine
15
Zidovudine
11
Bleomycin
11
Cyclophosphamide
9
Etoposide
8
Interferon alpha-2
6
Prednisone
5
Cytarabine
5
tecogalan
4
sargramostim
4
Rituximab
4
Polymerase Chain Reaction
4
Liposomes
4
Filgrastim
4
Dexamethasone
4
Methotrexate
3
Leucovorin
3
Fluorouracil
3
interferon alfa-n1
2
Watchful Waiting
2
Vinblastine
2
Tumor Necrosis Factor-alpha
2
Thalidomide
2
Semaxinib
2
Ritonavir
2
Peripheral Blood Stem Cell Transplantation
2
Mitoxantrone
2
Light Coagulation
2
Isotretinoin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
HIV Infections
×
Laser Therapy
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts